DEB-TACE combined with hepatic artery infusion chemotherapy might be an affordable treatment option for advanced stage of HCC

por Kondo, Yasuteru, Morosawa, Tatsuki, Minami, Soichiro, Tanaka, Yasuhito
Publicado 2022

Expression of EpCAM Increases in the Hepatitis B Related and the Treatment-Resistant Hepatocellular Carcinoma

por Kimura, Osamu, Kondo, Yasuteru, Kogure, Takayuki, Kakazu, Eiji, Ninomiya, Masashi, Iwata, Tomoaki, Morosawa, Tatsuki, Shimosegawa, Tooru
Publicado 2014

Acute-onset Autoimmune Hepatitis in a Patient with Selective Immunoglobulin M Deficiency

por Sano, Akitoshi, Inoue, Jun, Kakazu, Eiji, Ninomiya, Masashi, Iwata, Tomoaki, Morosawa, Tatsuki, Takai, Satoshi, Nakamura, Takuya, Masamune, Atsushi
Publicado 2019

Anti-nuclear antibody and a granuloma could be biomarkers for iCIs-related hepatitis by anti-PD-1 treatment

por Kondo, Yasuteru, Akahira, Junichi, Morosawa, Tatsuki, Toi, Yukihiro, Endo, Akashi, Satio, Hiroaki, Endo, Mareyuki, Sugawara, Shunichi, Tanaka, Yasuhito
Publicado 2022

PD-L1(+)MDSCs are increased in HCC patients and induced by soluble factor in the tumor microenvironment

por Iwata, Tomoaki, Kondo, Yasuteru, Kimura, Osamu, Morosawa, Tatsuki, Fujisaka, Yasuyuki, Umetsu, Teruyuki, Kogure, Takayuki, Inoue, Jun, Nakagome, Yu, Shimosegawa, Tooru
Publicado 2016

1(OH) Vitamin D3 Supplementation Improves the Sensitivity of the Immune-Response during Peg-IFN/RBV Therapy in Chronic Hepatitis C Patients-Case Controlled Trial

por Kondo, Yasuteru, Kato, Takanobu, Kimura, Osamu, Iwata, Tomoaki, Ninomiya, Masashi, Kakazu, Eiji, Miura, Masahito, Akahane, Takehiro, Miyazaki, Yutaka, Kobayashi, Tomoo, Ishii, Motoyasu, Kisara, Norihiro, Sasaki, Kumiko, Nakayama, Haruo, Igarashi, Takehiko, Obara, Noriyuki, Ueno, Yoshiyuki, Morosawa, Tatsuki, Shimosegawa, Tooru
Publicado 2013